Free Trial

Propanc Biopharma (PPCB) SEC Filings & 10K Form

Propanc Biopharma logo
$0.0002 0.00 (-33.33%)
(As of 12/20/2024 05:55 PM ET)

Recent Propanc Biopharma SEC Filings

DateFilerForm TypeView
12/20/2024
4:30 PM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
3:57 PM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
1:14 PM
Propanc Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2024
5:46 AM
Propanc Biopharma (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/30/2024
3:53 PM
Propanc Biopharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
09/27/2024
11:37 AM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
4:25 PM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
6:07 AM
Propanc Biopharma (Filer)
Form DEF 14C
08/14/2024
7:31 PM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
2:37 PM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
12:29 PM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
7:59 AM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:10 AM
Propanc Biopharma (Filer)
Form 8-K/A
06/12/2024
5:01 AM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
5:05 AM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
5:05 AM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
3:38 PM
Propanc Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/22/2024
11:12 AM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2024
3:20 PM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
2:15 PM
Propanc Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2024
1:39 PM
Propanc Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/14/2024
1:47 PM
Propanc Biopharma (Filer)
Form NT 10-Q
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:PPCB) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners